Biofidelity
Pre-clinicalCancer is a complex disease of the genome, which makes decisions about cancer care difficult–for providers and patients alike. Despite advances in genomics, many patients never get the biomarker testing they need to be matched with life-saving targeted therapies.1
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $99.5M
About
Cancer is a complex disease of the genome, which makes decisions about cancer care difficult–for providers and patients alike. Despite advances in genomics, many patients never get the biomarker testing they need to be matched with life-saving targeted therapies.1
Genetics & Genomics
Funding History
5Total raised:$99.5M
Series B$40MJul 15, 2023
Series A$25MJan 15, 2022
Series A$25MOct 15, 2021
Seed$4.5MSep 15, 2020